Closing the gaps in recruitment and retention in cancer trials: sufficient evidence but poor implementation
-
Published:2023-11
Issue:1
Volume:2
Page:e000195
-
ISSN:2752-7948
-
Container-title:BMJ Oncology
-
language:en
-
Short-container-title:bmjonc
Reference9 articles.
1. Patel MI , Ferguson JM , Castro E , et al . Racial and ethnic disparities in cancer care during the COVID-19 pandemic. JAMA Netw Open 2022;5:e2222009. doi:10.1001/jamanetworkopen.2022.22009
2. Witham MD , Anderson E , Carroll C , et al . Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-Stakeholder process. Trials 2020;21:694. doi:10.1186/s13063-020-04613-7
3. Dane A , Ashraf S , Timmis J , et al . Barriers to patient Enrolment in phase III cancer clinical trials: interviews with Clinicians and pharmaceutical industry representatives. BMJ Open 2022;12:e055165. doi:10.1136/bmjopen-2021-055165
4. Participation in Cancer Clinical Trials
5. Crocker JC , Ricci-Cabello I , Parker A , et al . Impact of patient and public involvement on Enrolment and retention in clinical trials: systematic review and meta-analysis. BMJ 2018;363:k4738. doi:10.1136/bmj.k4738